Client Update: An overhaul of regulation of software as a medical device – what’s on the horizon?
Proposed new regulatory rules for software as a medical device will, if enacted, have serious implications for suppliers to the Australian market, who will likely have to meet more stringent requirements that could conflict with those in the US and Europe. Special Counsel Ric Morgan and Senior Associate Tracy Lu look at the changes, and at what you should be considering now.